NASDAQ:OLMA | Insider Transactions — Page 2 | Olema Pharmaceuticals, Inc.

OLMA Insider Transactions — Page 2

271 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Bohen SeanPRESIDENT AND CEO2023-11-21Sale26,691.0$14.84
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2023-11-21Sale700.0$15.27
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2023-11-21Sale8,897.0$14.83
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-08Sale200.0$17.61
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-03Sale541.0$17.51
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-02Sale3,332.0$15.36
Harmon CyrusDirector2023-11-02Sale5,000.0$15.64
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-11-01Sale6,668.0$15.02
Harmon CyrusDirector2023-10-31Sale25,000.0$12.05
Harmon CyrusDirector2023-09-29Sale25,000.0$12.41
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF2023-09-19Sale20,000.0$12.67
Graham G. WalmsleyDirector2023-09-12Purchase508,130.0$9.84
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-09-12Purchase52,801.0$9.84
BVF PARTNERS L P/ILDirector,TenPercentOwner2023-09-12Purchase52,801.0$9.84
BVF INC/ILDirector,TenPercentOwner2023-09-12Purchase52,801.0$9.84
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-09-12Purchase52,801.0$9.84
LAMPERT MARK NDirector,TenPercentOwner2023-09-12Purchase52,801.0$9.84
Biotechnology Value Trading Fund OS LPDirector,Other2023-09-12Purchase52,801.0$9.84
BVF Partners OS Ltd.Director,Other2023-09-12Purchase52,801.0$9.84
BVF I GP LLCDirector,Other2023-09-12Purchase52,801.0$9.84
BVF II GP LLCDirector,Other2023-09-12Purchase52,801.0$9.84
BVF GP HOLDINGS LLCDirector,TenPercentOwner2023-09-12Purchase52,801.0$9.84
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-09-12Purchase677,853.0$9.84
BVF PARTNERS L P/ILDirector,TenPercentOwner2023-09-12Purchase677,853.0$9.84
BVF INC/ILDirector,TenPercentOwner2023-09-12Purchase677,853.0$9.84
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-09-12Purchase677,853.0$9.84
LAMPERT MARK NDirector,TenPercentOwner2023-09-12Purchase677,853.0$9.84
Biotechnology Value Trading Fund OS LPDirector,Other2023-09-12Purchase677,853.0$9.84
BVF Partners OS Ltd.Director,Other2023-09-12Purchase677,853.0$9.84
BVF I GP LLCDirector,Other2023-09-12Purchase677,853.0$9.84
BVF II GP LLCDirector,Other2023-09-12Purchase677,853.0$9.84
BVF GP HOLDINGS LLCDirector,TenPercentOwner2023-09-12Purchase677,853.0$9.84
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-09-12Purchase775,278.0$9.84
BVF PARTNERS L P/ILDirector,TenPercentOwner2023-09-12Purchase775,278.0$9.84
BVF INC/ILDirector,TenPercentOwner2023-09-12Purchase775,278.0$9.84
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-09-12Purchase775,278.0$9.84
LAMPERT MARK NDirector,TenPercentOwner2023-09-12Purchase775,278.0$9.84
Biotechnology Value Trading Fund OS LPDirector,Other2023-09-12Purchase775,278.0$9.84
BVF Partners OS Ltd.Director,Other2023-09-12Purchase775,278.0$9.84
BVF I GP LLCDirector,Other2023-09-12Purchase775,278.0$9.84
BVF II GP LLCDirector,Other2023-09-12Purchase775,278.0$9.84
BVF GP HOLDINGS LLCDirector,TenPercentOwner2023-09-12Purchase775,278.0$9.84
Harmon CyrusDirector2023-09-05Sale10,000.0$11.62
Harmon CyrusDirector2023-08-31Sale15,000.0$9.36
Harmon CyrusDirector2023-08-16Sale15,000.0$10.14
Harmon CyrusDirector2023-08-16Sale15,000.0$10.14
Harmon CyrusDirector2023-06-08Sale10,000.0$6.3
Harmon CyrusDirector2023-06-06Sale5,000.0$6.3
Harmon CyrusDirector2023-06-05Sale5,000.0$6.05
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2023-04-06Purchase10,000.0
Bohen SeanPRESIDENT AND CEO2022-09-21Purchase20,000.0
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.2022-09-02Purchase20,000.0
BIOTECHNOLOGY VALUE FUND L PDirectorOther2022-06-10Purchase41,417.0$4.03
BVF PARTNERS L P/ILDirector,TenPercentOwner2022-06-10Purchase41,417.0$4.03
BVF INC/ILDirector,TenPercentOwner2022-06-10Purchase41,417.0$4.03
BIOTECHNOLOGY VALUE FUND II LPDirectorOther2022-06-10Purchase41,417.0$4.03
LAMPERT MARK NDirector,TenPercentOwner2022-06-10Purchase41,417.0$4.03
Biotechnology Value Trading Fund OS LPDirectorOther2022-06-10Purchase41,417.0$4.03
BVF Partners OS Ltd.DirectorOther2022-06-10Purchase41,417.0$4.03
BVF I GP LLCDirectorOther2022-06-10Purchase41,417.0$4.03
BVF II GP LLCDirectorOther2022-06-10Purchase41,417.0$4.03
BVF GP HOLDINGS LLCDirector,TenPercentOwner2022-06-10Purchase41,417.0$4.03
BIOTECHNOLOGY VALUE FUND L PDirectorOther2022-06-10Purchase158,583.0$4.03
BVF PARTNERS L P/ILDirector,TenPercentOwner2022-06-10Purchase158,583.0$4.03
BVF INC/ILDirector,TenPercentOwner2022-06-10Purchase158,583.0$4.03
BIOTECHNOLOGY VALUE FUND II LPDirectorOther2022-06-10Purchase158,583.0$4.03
LAMPERT MARK NDirector,TenPercentOwner2022-06-10Purchase158,583.0$4.03
Biotechnology Value Trading Fund OS LPDirectorOther2022-06-10Purchase158,583.0$4.03
BVF Partners OS Ltd.DirectorOther2022-06-10Purchase158,583.0$4.03
BVF I GP LLCDirectorOther2022-06-10Purchase158,583.0$4.03
BVF II GP LLCDirectorOther2022-06-10Purchase158,583.0$4.03
BVF GP HOLDINGS LLCDirector,TenPercentOwner2022-06-10Purchase158,583.0$4.03
Horn KinneyCHIEF BUSINESS OFFICER2022-03-10Sale5,253.0$4.75
Horn KinneyCHIEF BUSINESS OFFICER2022-01-10Sale5,251.0$6.85
Horn KinneyCHIEF BUSINESS OFFICER2021-12-10Sale5,251.0$10.39
Myles David C.CHIEF DEVELOPMENT OFFICER2021-12-10Sale10,000.0$10.3
BIOTECHNOLOGY VALUE FUND L POther2021-11-30Purchase35,268.0$9.39
BVF PARTNERS L P/ILDirector,TenPercentOwner2021-11-30Purchase35,268.0$9.39
BVF INC/ILTenPercentOwner2021-11-30Purchase35,268.0$9.39
BIOTECHNOLOGY VALUE FUND II LPOther2021-11-30Purchase35,268.0$9.39
LAMPERT MARK NTenPercentOwner2021-11-30Purchase35,268.0$9.39
Biotechnology Value Trading Fund OS LPOther2021-11-30Purchase35,268.0$9.39
BVF Partners OS Ltd.Other2021-11-30Purchase35,268.0$9.39
BVF I GP LLCOther2021-11-30Purchase35,268.0$9.39
BVF II GP LLCOther2021-11-30Purchase35,268.0$9.39
BVF GP HOLDINGS LLCTenPercentOwner2021-11-30Purchase35,268.0$9.39
BIOTECHNOLOGY VALUE FUND L POther2021-11-30Purchase341,977.0$9.39
BVF PARTNERS L P/ILDirector,TenPercentOwner2021-11-30Purchase341,977.0$9.39
BVF INC/ILTenPercentOwner2021-11-30Purchase341,977.0$9.39
BIOTECHNOLOGY VALUE FUND II LPOther2021-11-30Purchase341,977.0$9.39
LAMPERT MARK NTenPercentOwner2021-11-30Purchase341,977.0$9.39
Biotechnology Value Trading Fund OS LPOther2021-11-30Purchase341,977.0$9.39
BVF Partners OS Ltd.Other2021-11-30Purchase341,977.0$9.39
BVF I GP LLCOther2021-11-30Purchase341,977.0$9.39
BVF II GP LLCOther2021-11-30Purchase341,977.0$9.39
BVF GP HOLDINGS LLCTenPercentOwner2021-11-30Purchase341,977.0$9.39
BIOTECHNOLOGY VALUE FUND L POther2021-11-30Purchase362,430.0$9.39
BVF PARTNERS L P/ILDirector,TenPercentOwner2021-11-30Purchase362,430.0$9.39
BVF INC/ILTenPercentOwner2021-11-30Purchase362,430.0$9.39
BIOTECHNOLOGY VALUE FUND II LPOther2021-11-30Purchase362,430.0$9.39